First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody
Patient dosing follows the completion of five single ascending dose cohorts involving healthy adult participants.
06 October 2026
06 October 2026
Patient dosing follows the completion of five single ascending dose cohorts involving healthy adult participants.
Combined with the AstraZeneca's genomic medicine facility, the site will accommodate around 2,000 researchers and scientists.
Indicated for TAVR, the Emboliner system is engineered to capture and extract debris generated during surgery.
The study evaluated 109 patients diagnosed with platinum-resistant ovarian cancer.
The investment adds to more than $7bn spent by Bayer on research, development, and manufacturing in the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.